![Gaurav D. Shah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gaurav D. Shah
Vorstandsvorsitzender bei
ROCKET PHARMACEUTICALS, INC.
Vermögen: 5 Mio $ am 31.07.2026
Profil
Gaurav D.
Shah is currently Chief Executive Officer & Director at Rocket Pharmaceuticals, Inc. since 2018, President, Chief Executive Officer & Director at Rocket Pharmaceuticals Ltd. since 2015, and Chairman at Anjarium Biosciences AG since 2022.
Former roles include Medical Director at Eli Lilly & Co. from 2010 to 2011, Independent Director at Talaris Therapeutics, Inc., Head-Global Clinical Program at Novartis Corp.
from 2011 to 2015, and Assistant Professor-Oncology at The Trustees of Columbia University in The City of New York from 2009 to 2011.
Education includes a doctorate from The Trustees of Columbia University in The City of New York and an undergraduate degree from Harvard College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.08.2026 | 1’462’832 ( 1.34% ) | 5 Mio $ | 31.07.2026 |
Aktive Positionen von Gaurav D. Shah
| Unternehmen | Position | Beginn |
|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Vorstandsvorsitzender | 04.01.2018 |
Rocket Pharmaceuticals Ltd.
 Rocket Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Provides gene therapy services | Vorstandsvorsitzender | 01.09.2015 |
Anjarium Biosciences AG
 Anjarium Biosciences AG BiotechnologyHealth Technology Develops non-viral gene therapy | Vorsitzender | 18.10.2022 |
Ehemalige bekannte Positionen von Gaurav D. Shah
| Unternehmen | Position | Ende |
|---|---|---|
Novartis Corp.
 Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Corporate Officer/Principal | 01.09.2015 |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.12.2011 |
| ELI LILLY AND COMPANY | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2011 |
| TOUE BIOPAR | Direktor/Vorstandsmitglied | - |
Ausbildung von Gaurav D. Shah
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
81
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmacitical products | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Talaris Therapeutics, Inc.
 Talaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Rocket Pharmaceuticals Ltd.
Rocket Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Provides gene therapy services | Health Technology |
Rocket Pharmaceuticals, Inc.
 Rocket Pharmaceuticals, Inc. BiotechnologyHealth Technology Provides gene therapy services | Health Technology |
Anjarium Biosciences AG
Anjarium Biosciences AG BiotechnologyHealth Technology Develops non-viral gene therapy | Health Technology |
